Regnum Corp. Share Price Other OTC
Equities
RGMP
US75915R1068
Biotechnology & Medical Research
Sales 2021 | - | Sales 2022 | - | Capitalization | 30.98L 26Cr |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | - |
Net Debt 2021 | 22.06T 18.41L | Net Debt 2022 | 8L 6.45Cr | EV / Sales 2022 | - |
P/E ratio 2021 |
-13
x | P/E ratio 2022 |
-3.97
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 1.18% |
1st Jan change | Capi. | |
---|---|---|
+29.77% | 4.95TCr | |
+1.00% | 4.26TCr | |
+49.62% | 4.25TCr | |
-5.26% | 2.91TCr | |
+13.68% | 2.66TCr | |
-22.99% | 1.86TCr | |
+8.22% | 1.32TCr | |
+32.41% | 1.25TCr | |
+24.01% | 1.21TCr |